Literature DB >> 22072634

The mPTP and its regulatory proteins: final common targets of signalling pathways for protection against necrosis.

Tetsuji Miura1, Masaya Tanno.   

Abstract

The mitochondrial permeability transition pore (mPTP) is a non-selective, large-conductance channel that is closed under physiological conditions. Opening of the mPTP, leading to abolition of mitochondrial functions, is a major mechanism of myocyte necrosis by ischaemia/reperfusion, and direct inhibition of mPTP opening by use of pharmacological or genetic manipulations limits infarct size in vivo. Multiple pro-survival signal pathways commonly target the mPTP and inhibit its opening. Although the molecular structure of the mPTP has not been established, recent studies have characterized roles of each mPTP subunit and functions of several proteins directly interacting with the mPTP. This article briefly describes the understanding of mPTP regulation and interaction of the mPTP with four proteins (hexokinase II, glycogen synthase kinase-3β, signal transducer and activator of transcription 3, and sirtuin 3) that are downstream of signal pathways relevant to protection from ischaemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072634     DOI: 10.1093/cvr/cvr302

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  37 in total

Review 1.  Hexokinases and cardioprotection.

Authors:  Guillaume Calmettes; Bernard Ribalet; Scott John; Paavo Korge; Peipei Ping; James N Weiss
Journal:  J Mol Cell Cardiol       Date:  2014-09-26       Impact factor: 5.000

Review 2.  Pharmacological modulation of mitochondrial ion channels.

Authors:  Luigi Leanza; Vanessa Checchetto; Lucia Biasutto; Andrea Rossa; Roberto Costa; Magdalena Bachmann; Mario Zoratti; Ildiko Szabo
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

3.  Mitochondrial dysfunction in uremic cardiomyopathy.

Authors:  David Taylor; Sunil Bhandari; Anne-Marie L Seymour
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

4.  Translocation of glycogen synthase kinase-3β (GSK-3β), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2).

Authors:  Masaya Tanno; Atsushi Kuno; Satoko Ishikawa; Takayuki Miki; Hidemichi Kouzu; Toshiyuki Yano; Hiromichi Murase; Toshiyuki Tobisawa; Makoto Ogasawara; Yoshiyuki Horio; Tetsuji Miura
Journal:  J Biol Chem       Date:  2014-09-03       Impact factor: 5.157

5.  Improvement of liver injury and survival by JNK2 and iNOS deficiency in liver transplants from cardiac death mice.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; Rick G Schnellmann; John J Lemasters; Zhi Zhong
Journal:  J Hepatol       Date:  2015-02-19       Impact factor: 25.083

6.  Does p53 Inhibition Suppress Myocardial Ischemia-Reperfusion Injury?

Authors:  Toshiyuki Yano; Koki Abe; Masaya Tanno; Takayuki Miki; Atsushi Kuno; Tetsuji Miura; Charles Steenbergen
Journal:  J Cardiovasc Pharmacol Ther       Date:  2018-03-19       Impact factor: 2.457

Review 7.  Epoxyeicosatrienoic acids and cardioprotection: the road to translation.

Authors:  Akinyemi Oni-Orisan; Nasser Alsaleh; Craig R Lee; John M Seubert
Journal:  J Mol Cell Cardiol       Date:  2014-06-02       Impact factor: 5.000

8.  Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.

Authors:  Hannah J Whittington; Idris Harding; Clemency I M Stephenson; Robert Bell; Derek J Hausenloy; Mihaela M Mocanu; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2013-05-30       Impact factor: 10.787

Review 9.  Novel therapeutic strategies for ischemic heart disease.

Authors:  Adam J Perricone; Richard S Vander Heide
Journal:  Pharmacol Res       Date:  2014-09-01       Impact factor: 7.658

10.  Sustained Oligomycin Sensitivity Conferring Protein Expression in Cardiomyocytes Protects Against Cardiac hypertrophy Induced by Pressure Overload via Improving Mitochondrial Function.

Authors:  Yingying Guo; Kailiang Zhang; Xu Gao; Zhou Zhou; Zhiheng Liu; Kevin Yang; Kai Huang; Qinglin Yang; Qinqiang Long
Journal:  Hum Gene Ther       Date:  2020-09-21       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.